HilleVax (HLVX)
(Real Time Quote from BATS)
$1.89 USD
+0.05 (2.72%)
Updated Jul 25, 2024 10:47 AM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for HilleVax, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -123.57 | -159.81 | -102.41 | NA | NA |
Depreciation/Amortization & Depletion | -0.20 | 0.29 | 0.00 | NA | NA |
Net Change from Assets/Liabilities | 22.84 | -5.40 | 11.28 | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | NA |
Other Operating Activities | 14.14 | 102.93 | 83.84 | NA | NA |
Net Cash From Operating Activities | -86.78 | -61.99 | -7.30 | NA | NA |
Property & Equipment | -10.75 | -6.51 | -2.81 | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | NA |
Investments | -83.89 | 0.00 | 0.00 | NA | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | NA | NA |
Net Cash from Investing Activities | -94.64 | -6.51 | -2.81 | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 108.90 | 230.01 | 0.00 | NA | NA |
Issuance (Repayment) of Debt | 9.80 | 14.67 | 0.00 | NA | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 135.00 | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | NA |
Other Financing Activities | 0.00 | -19.70 | -0.79 | NA | NA |
Net Cash from Financing Activities | 118.70 | 224.97 | 134.21 | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | -62.72 | 156.47 | 124.11 | NA | NA |
Cash at Beginning of Period | 281.03 | 124.57 | 0.46 | NA | NA |
Cash at End of Period | 218.31 | 281.03 | 124.57 | NA | NA |
Diluted Net EPS | -3.04 | -5.89 | -18.22 | NA | NA |
Fiscal Year End for HilleVax, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -46.83 | -123.57 | -86.61 | -54.79 |
Depreciation/Amortization & Depletion | NA | -0.43 | -0.20 | -0.03 | 0.43 |
Net Change from Assets/Liabilities | NA | -6.43 | 22.84 | 11.25 | 9.90 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 20.69 | 14.14 | 10.21 | 6.09 |
Net Cash From Operating Activities | NA | -33.00 | -86.78 | -65.18 | -38.37 |
Property & Equipment | NA | -13.98 | -10.75 | -10.01 | -7.82 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -43.68 | -83.89 | -114.10 | -85.11 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -57.66 | -94.64 | -124.11 | -92.93 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 15.06 | 108.90 | 108.59 | 0.48 |
Issuance (Repayment) of Debt | NA | 0.00 | 9.80 | 9.80 | 9.80 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 15.06 | 118.70 | 118.39 | 10.28 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -75.60 | -62.72 | -70.90 | -121.03 |
Cash at Beginning of Period | NA | 218.31 | 281.03 | 281.03 | 281.03 |
Cash at End of Period | NA | 142.71 | 218.31 | 210.13 | 160.01 |
Diluted Net EPS | NA | -0.97 | -0.78 | -0.81 | -0.74 |